Channa Jayasena is Clinical Senior Lecturer and Consultant in Reproductive Endocrinology and Andrology at Imperial College and Hammersmith Hospital, London. Dr. Jayasena qualified in medicine at Cambridge University, after which he undertook specialist training in Diabetes & Endocrinology in London. Having been awarded a Wellcome Trust Clinical Research Training Fellowship and NIHR Clinical Lectureship, he conducted first-to-human studies at Imperial College investigating the clinical effects of novel hypothalamic neuropeptides such as kisspeptin on the human reproductive axis. He is currently Clinical Lead for Male Infertility / Andrology at Hammersmith Hospital which has developed cutting edge techniques such as seminal reactive oxygen species (ROS) measurement, microsurgical testicular sperm extraction (mTESE) and testicular mapping. His current research focuses on developing novel diagnostics and therapeutics for men with disorders of spermatogenesis.
et al., 2016, Kisspeptin signaling in the amygdala modulates reproductive hormone secretion, Brain Structure & Function, Vol:221, ISSN:1863-2653, Pages:2035-2047
Dwyer AA, Jayasena CN, Quinton R, 2016, Congenital hypogonadotropic hypogonadism: implications of absent mini-puberty, Minerva Endocrinologica, Vol:41, ISSN:0391-1977, Pages:188-195
et al., 2016, Novel circulating placental markers prokineticin-1, soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriage., Hum Reprod, Vol:31, Pages:2681-2688
et al., 2016, Subcutaneous infusion of kisspeptin-54 stimulates gonadotrophin release in women and the response correlates with basal oestradiol levels, Clinical Endocrinology, Vol:84, ISSN:0300-0664, Pages:939-945
et al., 2016, Investigating the KNDy Hypothesis in Humans by Coadministration of Kisspeptin, Neurokinin B, and Naltrexone in Men., J Clin Endocrinol Metab, Vol:101, Pages:3429-3436